Literature DB >> 26228674

Medical nutrition therapy is the essential cornerstone for effective treatment of "refractory" severe hypertriglyceridemia regardless of pharmaceutical treatment: Evidence from a Lipid Management Program.

Katherine S Rhodes1, Martha Weintraub2, Elizabeth H Marchlewicz3, Melvyn Rubenfire2, Robert D Brook2.   

Abstract

BACKGROUND: Patients with refractory severe hypertriglyceridemia are at risk of pancreatitis and cardiovascular disease. The role of individualized nutrition therapy in these patients independent of pharmaceutical treatment has not been documented.
OBJECTIVE: To document the effect of nutrition intervention on severe hypertriglyceridemia regardless of medication status or prior nutrition counseling.
METHODS: Outcomes of new patients with triglycerides ≥ 500 mg/dL presenting to a Lipid Management Program over a 6-year period were tracked. Patients received comprehensive laboratory assessment, nutrition assessment, and initiation of an individualized diet intervention before seeing the lipidologist. Clinical and behavioral outcomes were recorded.
RESULTS: In all, 168 patients (117 men; mean age, 49.03 ± 11.22 years; body mass index, 32.61 ± 5.85 kg/m(2); 110 (65.5%) on lipid-lowering medications) returned for assessment of nutrition intervention. Triglycerides were reduced from median (interquartile range) 961.5 (611.5-1785.3) to 493.0 (337-736.3) mg/dL (P < .0001 for log transformation of triglycerides). There was no difference in median percentage reduction in triglycerides after nutrition intervention between those not on lipid-lowering medication, on a fibric acid derivative, on other lipid-lowering medication, or on a combination of lipid-lowering medications (P = .376) in a median (interquartile range) of 5 (3-7) weeks. Effect was independent of prior nutrition counseling (P = .260). Reported percentage fat in the diet at second visit correlated with log-transformed triglycerides achieved, independent of initial triglycerides level (r = 0.290; P = .001).
CONCLUSIONS: Individualized nutrition therapy results in changes in eating behavior and reductions in triglyceride levels in patients with refractory severe hypertriglyceridemia independent of lipid-lowering medication(s) and prior nutrition counseling.
Copyright © 2015 National Lipid Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular; Medical nutrition therapy; Pancreatitis; Severe hypertriglyceridemia; Triglycerides

Mesh:

Substances:

Year:  2015        PMID: 26228674     DOI: 10.1016/j.jacl.2015.03.012

Source DB:  PubMed          Journal:  J Clin Lipidol        ISSN: 1876-4789            Impact factor:   4.766


  4 in total

1.  A Clinical Case of a Homozygous Deletion in the APOA5 Gene with Severe Hypertriglyceridemia.

Authors:  Petr Andreevich Vasiluev; Olga N Ivanova; Natalia A Semenova; Tatiana V Strokova; Natalia N Taran; Uliana V Chubykina; Marat V Ezhov; Ekaterina Y Zakharova; Elena L Dadli; Sergey I Kutsev
Journal:  Genes (Basel)       Date:  2022-06-14       Impact factor: 4.141

Review 2.  [Severe hypertriglyceridemia : Diagnostics and new treatment principles].

Authors:  U Kassner; M Dippel; E Steinhagen-Thiessen
Journal:  Internist (Berl)       Date:  2017-08       Impact factor: 0.743

3.  Primary Barriers of Adherence to a Structured Nutritional Intervention in Patients with Dyslipidemia.

Authors:  Fabiola Mabel Del Razo-Olvera; Angélica J Martin-Vences; Griselda X Brito-Córdova; Daniel Elías-López; María Victoria Landa-Anell; Marco Antonio Melgarejo-Hernández; Ivette Cruz-Bautista; Iliana Manjarrez-Martínez; Donají Verónica Gómez-Velasco; Carlos Alberto Aguilar-Salinas
Journal:  Nutrients       Date:  2021-05-21       Impact factor: 5.717

4.  A 7-day high-PUFA diet reduces angiopoietin-like protein 3 and 8 responses and postprandial triglyceride levels in healthy females but not males: a randomized control trial.

Authors:  Sepideh Kaviani; Caroline M Taylor; Jada L Stevenson; Jamie A Cooper; Chad M Paton
Journal:  BMC Nutr       Date:  2019-01-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.